Lucence Tissue500 - Comprehensive Genomic Profiling Test

Tissue500 can detect multiple classes of genomic alterations -single nucleotide variants,short insertions and deletions (indels), copy number variations (CNVs), microsatellite instability (MSI) status and tumor mutational burden (TMB)  in solid tumors.

572 genes : 71 fusions : MSI : TMB

• Improves therapy recommendations with comprehensive total nucleic acid (DNA+RNA) genomic analysis
• Matches patients to FDA-approved targeted therapies3 and available clinical trials
• Covers all solid tumor genes recommended by NCCN Guidelines4, ICGC5, and TCGA6